Home > Healthcare > Pharmaceuticals > Finished Drug Form > North America and Europe PEGylated Drugs Market

North America and Europe PEGylated Drugs Market Share

  • Report ID: GMI2511
  • Published Date: Apr 2018
  • Report Format: PDF
 Download Free Sample

North America and Europe PEGylated Drugs Market Share

Some of the major players of North America PEGylated drugs market are :

  • Merck
  • Shire Group
  • Amgen
  • UCB
  • AstraZeneca
  • Sigma Tau
  • Pfizer
  • Roche
  • Biogen

Prominent players are focusing on R&D activities for developing novel drugs using PEGylation technology for the treatment of chronic diseases to maintain their market position.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of North America and Europe pegylated drugs valued over USD 7.7 billion in 2017.

The industry share of North America and Europe pegylated drugs is expected to witness more than 5% CAGR from 2018 to 2024.

North America & Europe PEGylated Drugs Market Scope

  • North America & Europe PEGylated Drugs Market Size
  • North America & Europe PEGylated Drugs Market Analysis
  • North America & Europe PEGylated Drugs Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2017
    • Companies covered: 10
    • Tables & Figures: 39
    • Countries covered: 6
    • Pages: 100
     Download Free Sample
    ×
    Get a free sample of North America & Europe PEGylated Drugs Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.